These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9850046)

  • 1. Propagation of genetically altered tumor cells derived from fine-needle aspirates of primary breast carcinoma.
    Li Z; Bustos V; Miner J; Paulo E; Meng ZH; Zlotnikov G; Ljung BM; Dairkee SH
    Cancer Res; 1998 Dec; 58(23):5271-4. PubMed ID: 9850046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
    Gong Y; Booser DJ; Sneige N
    Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial enzymatic degradation of stroma allows enrichment and expansion of primary breast tumor cells.
    Dairkee SH; Paulo EC; Traquina P; Moore DH; Ljung BM; Smith HS
    Cancer Res; 1997 Apr; 57(8):1590-6. PubMed ID: 9108465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Origin of cells cultured in vitro from human breast carcinomas traced by cyclin D1 and HER2/neu FISH signal numbers.
    Matouskova E; Kudlackova I; Chaloupkova A; Brozova M; Netikova I; Vesely P
    Anticancer Res; 2005; 25(2A):1051-7. PubMed ID: 15868945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients.
    Martínez-Arribas F; Núñez-Villar MJ; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2003; 23(1B):565-8. PubMed ID: 12680147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The feasibility of using fine needle aspiration from primary breast cancers for cDNA microarray analyses.
    Assersohn L; Gangi L; Zhao Y; Dowsett M; Simon R; Powles TJ; Liu ET
    Clin Cancer Res; 2002 Mar; 8(3):794-801. PubMed ID: 11895911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER-2/neu detection in fine-needle aspirates of breast cancer: fluorescence in situ hybridization and immunocytochemical analysis.
    Beatty BG; Bryant R; Wang W; Ashikaga T; Gibson PC; Leiman G; Weaver DL
    Am J Clin Pathol; 2004 Aug; 122(2):246-55. PubMed ID: 15323142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide allelotyping of a new in vitro model system reveals early events in breast cancer progression.
    Li Z; Meng ZH; Sayeed A; Shalaby R; Ljung BM; Dairkee SH
    Cancer Res; 2002 Oct; 62(20):5980-7. PubMed ID: 12384566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer.
    Bouet-Toussaint F; Genetel N; Rioux-Leclercq N; Bansard JY; Levêque J; Guillé F; Patard JJ; Lesimple T; Catros-Quemener V
    Eur Cytokine Netw; 2000 Jun; 11(2):217-24. PubMed ID: 10903800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of features of human breast cancer cell lines and their corresponding tumors.
    Wistuba II; Behrens C; Milchgrub S; Syed S; Ahmadian M; Virmani AK; Kurvari V; Cunningham TH; Ashfaq R; Minna JD; Gazdar AF
    Clin Cancer Res; 1998 Dec; 4(12):2931-8. PubMed ID: 9865903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specimen adequacy and false-negative diagnosis rate in fine-needle aspirates of palpable breast masses.
    Boerner S; Sneige N
    Cancer; 1998 Dec; 84(6):344-8. PubMed ID: 9915135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of chromosomal aneusomy by fluorescence in situ hybridization in fine-needle aspirates from breast tumors: application to the preoperative diagnosis of breast carcinoma.
    Tsukamoto F; Miyoshi Y; Koyama H; Watatani M; Sasa M; Shiba E; Takami S; Inazawa J; Noguchi S
    Cancer; 2000 Dec; 90(6):373-8. PubMed ID: 11156521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literature.
    Brunelli M; Manfrin E; Miller K; Eccher A; Gobbo S; Reghellin D; Chilosi M; Remo A; Martignoni G; Menestrina F; Bonetti F
    J Cutan Pathol; 2009 Jun; 36(6):702-5. PubMed ID: 19515052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical evaluation of HER-2/neu on fine-needle aspirates from primary breast carcinomas.
    Nizzoli R; Bozzetti C; Crafa P; Naldi N; Guazzi A; Di Blasio B; Camisa R; Cascinu S
    Diagn Cytopathol; 2003 Mar; 28(3):142-6. PubMed ID: 12619096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
    Latta EK; Tjan S; Parkes RK; O'Malley FP
    Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
    Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
    Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients.
    Dairkee SH; Seok J; Champion S; Sayeed A; Mindrinos M; Xiao W; Davis RW; Goodson WH
    Cancer Res; 2008 Apr; 68(7):2076-80. PubMed ID: 18381411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of heterogeneous breast cancer with clonally expanded T-Cells in the HER2+ and metastasis of the HER2- tumor cells.
    Wiech T; Nikolopoulos E; Hausmann M; Walch A; Werner M; Fisch P
    Breast J; 2008; 14(5):487-91. PubMed ID: 18821935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
    Liu L; Gudas LJ
    J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.
    Palmieri D; Bronder JL; Herring JM; Yoneda T; Weil RJ; Stark AM; Kurek R; Vega-Valle E; Feigenbaum L; Halverson D; Vortmeyer AO; Steinberg SM; Aldape K; Steeg PS
    Cancer Res; 2007 May; 67(9):4190-8. PubMed ID: 17483330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.